These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 9723431

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation.
    Yu L, Wang Y, Fu SJ, Cheng XJ.
    Transplant Proc; 2000 Nov; 32(7):1709-10. PubMed ID: 11119902
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. FK 506 in kidney transplantation: results of the U.S.A. randomized comparative phase III study. The FK 506 Kidney Transplant Study Group.
    Miller J, Pirsch JD, Deierhoi M, Vincenti F, Filo RS.
    Transplant Proc; 1997 Nov; 29(1-2):304-5. PubMed ID: 9123008
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tacrolimus rescue therapy in late rejection after renal transplantation: outcome after 18 months.
    Budde K, Fritsche L, Smettan S, Schönberger B, Loening SA, Mai I, Bauer S, Waiser J, Neumayer HH.
    Transplant Proc; 1998 Jun; 30(4):1238-9. PubMed ID: 9636503
    [No Abstract] [Full Text] [Related]

  • 10. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
    Alloway RR, Russell WC, Gaber LW, Amiri MH, Vera SR, Gaber AO.
    Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prospective randomized study comparing FK 506 (Prograft) and cyclosporine A (Neoral) as primary immunosuppression in cadaveric renal transplants at a single institution: interim report of the first 80 cases.
    Morris-Stiff G, Singh J, Ostrowski K, Balaji V, Moore R, Darby C, Lord R, Jurewicz WA.
    Transplant Proc; 1998 Jun; 30(4):1295-6. PubMed ID: 9636525
    [No Abstract] [Full Text] [Related]

  • 13. Tacrolimus (FK 506) therapy in simultaneous pancreas kidney transplantation.
    Becker G, Witzke O, Friedrich J, Wagner K, Heemann U, Philipp T.
    Transplant Proc; 1996 Dec; 28(6):3169-70. PubMed ID: 8962228
    [No Abstract] [Full Text] [Related]

  • 14. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
    Woodle ES, Thistlethwaite JR, Haas M, Josephson MA, Newell KA, Bruce DS, Millis JM, Piper JB, Charette JI.
    Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of tacrolimus: clinically relevant aspects.
    Undre NA, Stevenson P, Schäfer A.
    Transplant Proc; 1999 Nov; 31(7A):21S-24S. PubMed ID: 10576037
    [No Abstract] [Full Text] [Related]

  • 16. A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation.
    Sperschneider H, European Renal Transplantation Study Group.
    Transplant Proc; 2001 Nov; 33(1-2):1279-81. PubMed ID: 11267291
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Conversion from cyclosporine to FK 506 as rescue therapy in renal transplantation with poorly steroid-responsive acute rejection.
    Morales E, Andrés A, Herrero JC, Dominguez-Gil B, Carreño A, Morales JM, Hernández E, Ortuño T, Praga M.
    Transplant Proc; 1999 Sep; 31(6):2248-9. PubMed ID: 10500562
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.